
This real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
This real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
Published: October 23rd 2015 | Updated: